Bank of Montreal
AGIO icon

Bank of Montreal’s Agios Pharmaceuticals AGIO Stock Holding History

Bank of Montreal’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-8,700
Closed -$460K – 4033
2016
Q3 		$460K Buy
8,700
+3,900
+81% +$170K ﹤0.01% 2115
2016
Q2 		$201K Buy
+4,800
New +$237K ﹤0.01% 2466

Other funds holding AGIO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of Montreal's AGIO Position: Q2 2023 in Review

Bank of Montreal sold out of Agios Pharmaceuticals (AGIO) in Q2 2023, closing a stake of 134,396 shares — an estimated $3.12M sold.

Bank of Montreal first reported a position in AGIO in Q1 2014 and held it in 32 quarters. The position peaked at $3.5M in Q4 2022. 153 funds tracked by Wall St. Rank hold AGIO as of Q2 2023.

  • Bank of Montreal reported no remaining Agios Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • Bank of Montreal sold 134,396 Agios Pharmaceuticals shares in Q2 2023, an estimated $3.12M.
  • Bank of Montreal first reported a position in Agios Pharmaceuticals in Q1 2014 and held it in 32 quarters.
  • Bank of Montreal's Agios Pharmaceuticals position peaked at $3.5M in Q4 2022.
  • 153 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2023.

Based on Bank of Montreal's 13F filing for Q2 2023, filed 2 Aug 2023.